Page last updated: 2024-11-13

iwr-1 endo

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

IWR-1-endo : A dicarboximide having an endo bridged phthalimide structure, substituted at nitrogen by a 4-(quinolin-8-ylcarbamoyl)benzoyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID44483163
CHEMBL ID562310
CHEBI ID62882
SCHEMBL ID15315470
MeSH IDM0590295

Synonyms (32)

Synonym
iwr-1
chebi:62882 ,
chembl562310 ,
bdbm50007583
iwr-1-endo
4-[(3ar,4s,7r,7as)-1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2h-4,7-methanoisoindol-2-yl]-n-(quinolin-8-yl)benzamide
1127442-82-3
rel-4-[(3ar,4s,7r,7as)-1,3,3a,4,7,7a-hexahydro-1,3-dioxo-4,7-methano-2h-isoindol-2-yl]-n-8-quinolinylbenzamide
BRD-K61314889-001-01-0
CCG-208104
HY-12238
iwr1-endo
SCHEMBL15315470
endo-iwr-1
irw1
4TKF
EX-A642
AKOS027326646
iwr-1 endo
benzamide, 4-[(3ar,4s,7r,7as)-1,3,3a,4,7,7a-hexahydro-1,3-dioxo-4,7-methano-2h-isoindol-2-yl]-n-8-quinolinyl-
iwr-1, >=98% (hplc)
4-[(1s,2r,6s,7r)-3,5-dioxo-4-azatricyclo[5.2.1.02,6]dec-8-en-4-yl]-n-quinolin-8-ylbenzamide
4-((3ar,4s,7r,7as)-1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2h-4,7-methanoisoindol-2-yl)-n-(quinolin-8-yl)benzamide
mfcd18086875
BCP05700
endo-iwr 1;iwr-1-endo
Q27132252
rel-4-((3ar,4s,7r,7as)-1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2h-4,7-methanoisoindol-2-yl)-n-(quinolin-8-yl)benzamide
C71420
nsc-756646
nsc756646
AC-35923
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
axin stabilizernull
Wnt signalling inhibitorA substance that inhibits any of the Wnt signalling pathway, a group of signal transduction pathways made of proteins that pass signals from outside of a cell through cell surface receptors to the inside of the cell.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
dicarboximideAn imide in which the two acyl substituents on nitrogen are carboacyl groups.
bridged compoundA polycyclic compound in which two rings have two or more atoms in common.
quinolinesA class of aromatic heterocyclic compounds each of which contains a benzene ring ortho fused to carbons 2 and 3 of a pyridine ring.
benzamides
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (6)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Poly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)IC50 (µMol)22.80220.00190.62935.0000AID1866925; AID661305; AID722001; AID722004; AID748259; AID748264
Poly [ADP-ribose] polymerase 1Homo sapiens (human)IC50 (µMol)55.61250.00020.81239.8100AID1866927; AID661303; AID661310; AID748262
Poly [ADP-ribose] polymerase tankyrase-2Mus musculus (house mouse)IC50 (µMol)0.05600.05600.05600.0560AID1128299
Poly [ADP-ribose] polymerase tankyrase-1Mus musculus (house mouse)IC50 (µMol)0.13100.13100.13100.1310AID1128298
Poly [ADP-ribose] polymerase tankyrase-2Homo sapiens (human)IC50 (µMol)17.08860.00210.67505.1300AID1428393; AID1866926; AID661306; AID722001; AID722003; AID748259; AID748263
Poly [ADP-ribose] polymerase 2Homo sapiens (human)IC50 (µMol)53.49000.00010.21886.6000AID1866928; AID661304; AID661311; AID722002; AID748261
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Poly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)EC50 (µMol)2.50002.50002.50002.5000AID748260
Poly [ADP-ribose] polymerase tankyrase-2Homo sapiens (human)EC50 (µMol)1.35000.20002.56675.0000AID661307; AID748260
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (79)

Processvia Protein(s)Taxonomy
peptidyl-serine phosphorylationPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
peptidyl-threonine phosphorylationPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
protein polyubiquitinationPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
mitotic spindle organizationPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
protein transportPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
Wnt signaling pathwayPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
regulation of telomere maintenance via telomerasePoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
positive regulation of telomere maintenance via telomerasePoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
mRNA transportPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
spindle assemblyPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
cell divisionPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
positive regulation of telomerase activityPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
protein localization to chromosome, telomeric regionPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
protein poly-ADP-ribosylationPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
protein auto-ADP-ribosylationPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
positive regulation of canonical Wnt signaling pathwayPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
positive regulation of telomere cappingPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
negative regulation of telomere maintenance via telomere lengtheningPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
negative regulation of telomeric DNA bindingPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
negative regulation of maintenance of mitotic sister chromatid cohesion, telomericPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
DNA damage responsePoly [ADP-ribose] polymerase 1Homo sapiens (human)
mitochondrion organizationPoly [ADP-ribose] polymerase 1Homo sapiens (human)
mitochondrial DNA metabolic processPoly [ADP-ribose] polymerase 1Homo sapiens (human)
regulation of protein localizationPoly [ADP-ribose] polymerase 1Homo sapiens (human)
cellular response to oxidative stressPoly [ADP-ribose] polymerase 1Homo sapiens (human)
protein modification processPoly [ADP-ribose] polymerase 1Homo sapiens (human)
mitochondrial DNA repairPoly [ADP-ribose] polymerase 1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIPoly [ADP-ribose] polymerase 1Homo sapiens (human)
telomere maintenancePoly [ADP-ribose] polymerase 1Homo sapiens (human)
DNA repairPoly [ADP-ribose] polymerase 1Homo sapiens (human)
double-strand break repairPoly [ADP-ribose] polymerase 1Homo sapiens (human)
transcription by RNA polymerase IIPoly [ADP-ribose] polymerase 1Homo sapiens (human)
apoptotic processPoly [ADP-ribose] polymerase 1Homo sapiens (human)
DNA damage responsePoly [ADP-ribose] polymerase 1Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayPoly [ADP-ribose] polymerase 1Homo sapiens (human)
response to gamma radiationPoly [ADP-ribose] polymerase 1Homo sapiens (human)
positive regulation of cardiac muscle hypertrophyPoly [ADP-ribose] polymerase 1Homo sapiens (human)
carbohydrate biosynthetic processPoly [ADP-ribose] polymerase 1Homo sapiens (human)
protein autoprocessingPoly [ADP-ribose] polymerase 1Homo sapiens (human)
signal transduction involved in regulation of gene expressionPoly [ADP-ribose] polymerase 1Homo sapiens (human)
macrophage differentiationPoly [ADP-ribose] polymerase 1Homo sapiens (human)
DNA ADP-ribosylationPoly [ADP-ribose] polymerase 1Homo sapiens (human)
positive regulation of DNA-templated transcription, elongationPoly [ADP-ribose] polymerase 1Homo sapiens (human)
cellular response to insulin stimulusPoly [ADP-ribose] polymerase 1Homo sapiens (human)
positive regulation of intracellular estrogen receptor signaling pathwayPoly [ADP-ribose] polymerase 1Homo sapiens (human)
negative regulation of transcription elongation by RNA polymerase IIPoly [ADP-ribose] polymerase 1Homo sapiens (human)
cellular response to UVPoly [ADP-ribose] polymerase 1Homo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionPoly [ADP-ribose] polymerase 1Homo sapiens (human)
innate immune responsePoly [ADP-ribose] polymerase 1Homo sapiens (human)
regulation of circadian sleep/wake cycle, non-REM sleepPoly [ADP-ribose] polymerase 1Homo sapiens (human)
negative regulation of innate immune responsePoly [ADP-ribose] polymerase 1Homo sapiens (human)
negative regulation of DNA-templated transcriptionPoly [ADP-ribose] polymerase 1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIPoly [ADP-ribose] polymerase 1Homo sapiens (human)
decidualizationPoly [ADP-ribose] polymerase 1Homo sapiens (human)
regulation of catalytic activityPoly [ADP-ribose] polymerase 1Homo sapiens (human)
positive regulation of mitochondrial depolarizationPoly [ADP-ribose] polymerase 1Homo sapiens (human)
positive regulation of SMAD protein signal transductionPoly [ADP-ribose] polymerase 1Homo sapiens (human)
positive regulation of necroptotic processPoly [ADP-ribose] polymerase 1Homo sapiens (human)
protein poly-ADP-ribosylationPoly [ADP-ribose] polymerase 1Homo sapiens (human)
protein auto-ADP-ribosylationPoly [ADP-ribose] polymerase 1Homo sapiens (human)
protein localization to chromatinPoly [ADP-ribose] polymerase 1Homo sapiens (human)
cellular response to zinc ionPoly [ADP-ribose] polymerase 1Homo sapiens (human)
replication fork reversalPoly [ADP-ribose] polymerase 1Homo sapiens (human)
negative regulation of cGAS/STING signaling pathwayPoly [ADP-ribose] polymerase 1Homo sapiens (human)
positive regulation of protein localization to nucleusPoly [ADP-ribose] polymerase 1Homo sapiens (human)
regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathwayPoly [ADP-ribose] polymerase 1Homo sapiens (human)
positive regulation of single strand break repairPoly [ADP-ribose] polymerase 1Homo sapiens (human)
response to aldosteronePoly [ADP-ribose] polymerase 1Homo sapiens (human)
negative regulation of adipose tissue developmentPoly [ADP-ribose] polymerase 1Homo sapiens (human)
negative regulation of telomere maintenance via telomere lengtheningPoly [ADP-ribose] polymerase 1Homo sapiens (human)
cellular response to amyloid-betaPoly [ADP-ribose] polymerase 1Homo sapiens (human)
positive regulation of myofibroblast differentiationPoly [ADP-ribose] polymerase 1Homo sapiens (human)
regulation of base-excision repairPoly [ADP-ribose] polymerase 1Homo sapiens (human)
positive regulation of double-strand break repair via homologous recombinationPoly [ADP-ribose] polymerase 1Homo sapiens (human)
cellular response to nerve growth factor stimulusPoly [ADP-ribose] polymerase 1Homo sapiens (human)
ATP generation from poly-ADP-D-ribosePoly [ADP-ribose] polymerase 1Homo sapiens (human)
negative regulation of ATP biosynthetic processPoly [ADP-ribose] polymerase 1Homo sapiens (human)
protein polyubiquitinationPoly [ADP-ribose] polymerase tankyrase-2Homo sapiens (human)
Wnt signaling pathwayPoly [ADP-ribose] polymerase tankyrase-2Homo sapiens (human)
positive regulation of telomere maintenance via telomerasePoly [ADP-ribose] polymerase tankyrase-2Homo sapiens (human)
protein localization to chromosome, telomeric regionPoly [ADP-ribose] polymerase tankyrase-2Homo sapiens (human)
protein poly-ADP-ribosylationPoly [ADP-ribose] polymerase tankyrase-2Homo sapiens (human)
protein auto-ADP-ribosylationPoly [ADP-ribose] polymerase tankyrase-2Homo sapiens (human)
positive regulation of canonical Wnt signaling pathwayPoly [ADP-ribose] polymerase tankyrase-2Homo sapiens (human)
positive regulation of telomere cappingPoly [ADP-ribose] polymerase tankyrase-2Homo sapiens (human)
negative regulation of telomere maintenance via telomere lengtheningPoly [ADP-ribose] polymerase tankyrase-2Homo sapiens (human)
DNA repairPoly [ADP-ribose] polymerase 2Homo sapiens (human)
base-excision repairPoly [ADP-ribose] polymerase 2Homo sapiens (human)
DNA damage responsePoly [ADP-ribose] polymerase 2Homo sapiens (human)
DNA ADP-ribosylationPoly [ADP-ribose] polymerase 2Homo sapiens (human)
decidualizationPoly [ADP-ribose] polymerase 2Homo sapiens (human)
positive regulation of cell growth involved in cardiac muscle cell developmentPoly [ADP-ribose] polymerase 2Homo sapiens (human)
protein poly-ADP-ribosylationPoly [ADP-ribose] polymerase 2Homo sapiens (human)
protein auto-ADP-ribosylationPoly [ADP-ribose] polymerase 2Homo sapiens (human)
response to oxygen-glucose deprivationPoly [ADP-ribose] polymerase 2Homo sapiens (human)
extrinsic apoptotic signaling pathwayPoly [ADP-ribose] polymerase 2Homo sapiens (human)
hippocampal neuron apoptotic processPoly [ADP-ribose] polymerase 2Homo sapiens (human)
DNA repair-dependent chromatin remodelingPoly [ADP-ribose] polymerase 2Homo sapiens (human)
double-strand break repairPoly [ADP-ribose] polymerase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (34)

Processvia Protein(s)Taxonomy
NAD+ ADP-ribosyltransferase activityPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
protein bindingPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
zinc ion bindingPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
nucleotidyltransferase activityPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
histone bindingPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
NAD+-protein ADP-ribosyltransferase activityPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
DNA bindingPoly [ADP-ribose] polymerase 1Homo sapiens (human)
chromatin bindingPoly [ADP-ribose] polymerase 1Homo sapiens (human)
damaged DNA bindingPoly [ADP-ribose] polymerase 1Homo sapiens (human)
RNA bindingPoly [ADP-ribose] polymerase 1Homo sapiens (human)
NAD+ ADP-ribosyltransferase activityPoly [ADP-ribose] polymerase 1Homo sapiens (human)
protein bindingPoly [ADP-ribose] polymerase 1Homo sapiens (human)
zinc ion bindingPoly [ADP-ribose] polymerase 1Homo sapiens (human)
nucleotidyltransferase activityPoly [ADP-ribose] polymerase 1Homo sapiens (human)
enzyme bindingPoly [ADP-ribose] polymerase 1Homo sapiens (human)
protein kinase bindingPoly [ADP-ribose] polymerase 1Homo sapiens (human)
nuclear estrogen receptor bindingPoly [ADP-ribose] polymerase 1Homo sapiens (human)
nucleosome bindingPoly [ADP-ribose] polymerase 1Homo sapiens (human)
ubiquitin protein ligase bindingPoly [ADP-ribose] polymerase 1Homo sapiens (human)
identical protein bindingPoly [ADP-ribose] polymerase 1Homo sapiens (human)
protein homodimerization activityPoly [ADP-ribose] polymerase 1Homo sapiens (human)
histone deacetylase bindingPoly [ADP-ribose] polymerase 1Homo sapiens (human)
NAD bindingPoly [ADP-ribose] polymerase 1Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingPoly [ADP-ribose] polymerase 1Homo sapiens (human)
R-SMAD bindingPoly [ADP-ribose] polymerase 1Homo sapiens (human)
NAD DNA ADP-ribosyltransferase activityPoly [ADP-ribose] polymerase 1Homo sapiens (human)
transcription regulator activator activityPoly [ADP-ribose] polymerase 1Homo sapiens (human)
NAD+-protein-serine ADP-ribosyltransferase activityPoly [ADP-ribose] polymerase 1Homo sapiens (human)
NAD+- protein-aspartate ADP-ribosyltransferase activityPoly [ADP-ribose] polymerase 1Homo sapiens (human)
NAD+-protein-glutamate ADP-ribosyltransferase activityPoly [ADP-ribose] polymerase 1Homo sapiens (human)
NAD+-protein-tyrosine ADP-ribosyltransferase activityPoly [ADP-ribose] polymerase 1Homo sapiens (human)
NAD+-protein-histidine ADP-ribosyltransferase activityPoly [ADP-ribose] polymerase 1Homo sapiens (human)
NAD+-histone H2BS6 serine ADP-ribosyltransferase activityPoly [ADP-ribose] polymerase 1Homo sapiens (human)
NAD+-histone H3S10 serine ADP-ribosyltransferase activityPoly [ADP-ribose] polymerase 1Homo sapiens (human)
NAD+-histone H2BE35 glutamate ADP-ribosyltransferase activityPoly [ADP-ribose] polymerase 1Homo sapiens (human)
NAD+-protein ADP-ribosyltransferase activityPoly [ADP-ribose] polymerase 1Homo sapiens (human)
NAD+ ADP-ribosyltransferase activityPoly [ADP-ribose] polymerase tankyrase-2Homo sapiens (human)
protein bindingPoly [ADP-ribose] polymerase tankyrase-2Homo sapiens (human)
nucleotidyltransferase activityPoly [ADP-ribose] polymerase tankyrase-2Homo sapiens (human)
enzyme bindingPoly [ADP-ribose] polymerase tankyrase-2Homo sapiens (human)
metal ion bindingPoly [ADP-ribose] polymerase tankyrase-2Homo sapiens (human)
NAD+-protein ADP-ribosyltransferase activityPoly [ADP-ribose] polymerase tankyrase-2Homo sapiens (human)
chromatin bindingPoly [ADP-ribose] polymerase 2Homo sapiens (human)
damaged DNA bindingPoly [ADP-ribose] polymerase 2Homo sapiens (human)
NAD+ ADP-ribosyltransferase activityPoly [ADP-ribose] polymerase 2Homo sapiens (human)
protein bindingPoly [ADP-ribose] polymerase 2Homo sapiens (human)
nucleotidyltransferase activityPoly [ADP-ribose] polymerase 2Homo sapiens (human)
nucleosome bindingPoly [ADP-ribose] polymerase 2Homo sapiens (human)
poly-ADP-D-ribose bindingPoly [ADP-ribose] polymerase 2Homo sapiens (human)
NAD DNA ADP-ribosyltransferase activityPoly [ADP-ribose] polymerase 2Homo sapiens (human)
NAD+-protein-serine ADP-ribosyltransferase activityPoly [ADP-ribose] polymerase 2Homo sapiens (human)
NAD+- protein-aspartate ADP-ribosyltransferase activityPoly [ADP-ribose] polymerase 2Homo sapiens (human)
NAD+-protein-glutamate ADP-ribosyltransferase activityPoly [ADP-ribose] polymerase 2Homo sapiens (human)
poly-ADP-D-ribose modification-dependent protein bindingPoly [ADP-ribose] polymerase 2Homo sapiens (human)
NAD+-protein ADP-ribosyltransferase activityPoly [ADP-ribose] polymerase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (24)

Processvia Protein(s)Taxonomy
Golgi membranePoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
pericentriolar materialPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
chromosome, telomeric regionPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
nucleoplasmPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
Golgi apparatusPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
cytosolPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
nuclear bodyPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
nuclear membranePoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
mitotic spindle polePoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
nuclear porePoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
nucleusPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
cytoplasmPoly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)
nucleusPoly [ADP-ribose] polymerase 1Homo sapiens (human)
cytosolPoly [ADP-ribose] polymerase 1Homo sapiens (human)
site of double-strand breakPoly [ADP-ribose] polymerase 1Homo sapiens (human)
nuclear replication forkPoly [ADP-ribose] polymerase 1Homo sapiens (human)
site of DNA damagePoly [ADP-ribose] polymerase 1Homo sapiens (human)
chromosome, telomeric regionPoly [ADP-ribose] polymerase 1Homo sapiens (human)
nucleusPoly [ADP-ribose] polymerase 1Homo sapiens (human)
nuclear envelopePoly [ADP-ribose] polymerase 1Homo sapiens (human)
nucleoplasmPoly [ADP-ribose] polymerase 1Homo sapiens (human)
nucleolusPoly [ADP-ribose] polymerase 1Homo sapiens (human)
mitochondrionPoly [ADP-ribose] polymerase 1Homo sapiens (human)
membranePoly [ADP-ribose] polymerase 1Homo sapiens (human)
nuclear bodyPoly [ADP-ribose] polymerase 1Homo sapiens (human)
site of double-strand breakPoly [ADP-ribose] polymerase 1Homo sapiens (human)
site of DNA damagePoly [ADP-ribose] polymerase 1Homo sapiens (human)
chromatinPoly [ADP-ribose] polymerase 1Homo sapiens (human)
transcription regulator complexPoly [ADP-ribose] polymerase 1Homo sapiens (human)
protein-containing complexPoly [ADP-ribose] polymerase 1Homo sapiens (human)
protein-DNA complexPoly [ADP-ribose] polymerase 1Homo sapiens (human)
nucleolusPoly [ADP-ribose] polymerase 1Homo sapiens (human)
Golgi membranePoly [ADP-ribose] polymerase tankyrase-2Homo sapiens (human)
pericentriolar materialPoly [ADP-ribose] polymerase tankyrase-2Homo sapiens (human)
chromosome, telomeric regionPoly [ADP-ribose] polymerase tankyrase-2Homo sapiens (human)
nucleusPoly [ADP-ribose] polymerase tankyrase-2Homo sapiens (human)
nuclear envelopePoly [ADP-ribose] polymerase tankyrase-2Homo sapiens (human)
cytoplasmPoly [ADP-ribose] polymerase tankyrase-2Homo sapiens (human)
cytosolPoly [ADP-ribose] polymerase tankyrase-2Homo sapiens (human)
perinuclear region of cytoplasmPoly [ADP-ribose] polymerase tankyrase-2Homo sapiens (human)
cytoplasmPoly [ADP-ribose] polymerase tankyrase-2Homo sapiens (human)
nucleusPoly [ADP-ribose] polymerase tankyrase-2Homo sapiens (human)
site of DNA damagePoly [ADP-ribose] polymerase 2Homo sapiens (human)
nucleusPoly [ADP-ribose] polymerase 2Homo sapiens (human)
nucleoplasmPoly [ADP-ribose] polymerase 2Homo sapiens (human)
nucleolusPoly [ADP-ribose] polymerase 2Homo sapiens (human)
site of DNA damagePoly [ADP-ribose] polymerase 2Homo sapiens (human)
nucleolusPoly [ADP-ribose] polymerase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (102)

Assay IDTitleYearJournalArticle
AID649227Inhibition of beta-casein-dependent canonical Wnt3 pathway in human HEK293T cells by luciferase reporter gene assay2012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Wnt inhibition correlates with human embryonic stem cell cardiomyogenesis: a structure-activity relationship study based on inhibitors for the Wnt response.
AID748262Inhibition of PARP1 (unknown origin) using histone as substrate after 1 hr by luminescence assay2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Discovery of novel, induced-pocket binding oxazolidinones as potent, selective, and orally bioavailable tankyrase inhibitors.
AID661315Selectivity ratio of IC50 for human PARP2 to IC50 for human TNSK22012Journal of medicinal chemistry, Feb-09, Volume: 55, Issue:3
Structural basis of selective inhibition of human tankyrases.
AID748257Intrinsic clearance in rat liver microsomes2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Discovery of novel, induced-pocket binding oxazolidinones as potent, selective, and orally bioavailable tankyrase inhibitors.
AID525416Induction of Axin2 accumulation in human DLD1 cells by Western blot analysis2009Nature chemical biology, Feb, Volume: 5, Issue:2
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
AID525196Effect on Axin2 subcellular redistribution in african green monkey Cos1 cells by immunostaining method2009Nature chemical biology, Feb, Volume: 5, Issue:2
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
AID525202Effect on interaction between Axin1-GFP and CK1epsilon in HEK293 cell lysate at 10 uM by Western blot analysis2009Nature chemical biology, Feb, Volume: 5, Issue:2
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
AID1428387Inhibition of full length recombinant human His6-tagged PARP2 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay2017Journal of medicinal chemistry, 02-23, Volume: 60, Issue:4
Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors.
AID722001Inhibition of Tankyrase in human HEK293 cells assessed as inhibition of Wnt pathway by Wnt3a-induced STF assay2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
Discovery of a class of novel tankyrase inhibitors that bind to both the nicotinamide pocket and the induced pocket.
AID661309Selectivity ratio of IC50 for PARP2 to IC50 for TNSK22012Journal of medicinal chemistry, Feb-09, Volume: 55, Issue:3
Structural basis of selective inhibition of human tankyrases.
AID748253Selectivity ratio of IC50 for PARP2 (unknown origin) to IC50 for tankyrase2 (unknown origin)2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Discovery of novel, induced-pocket binding oxazolidinones as potent, selective, and orally bioavailable tankyrase inhibitors.
AID748259Inhibition of tankyrase in human SW480 cells assessed as degradation of beta catenin after 40 to 48 hrs2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Discovery of novel, induced-pocket binding oxazolidinones as potent, selective, and orally bioavailable tankyrase inhibitors.
AID525201Effect on interaction between Axin1-GFP and GSK3-beta in HEK293 cell lysate at 10 uM by Western blot analysis2009Nature chemical biology, Feb, Volume: 5, Issue:2
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
AID525447Inhibition of Wnt1/beta-casein pathway activity in mouse L cell expressing Wnt1 and STF assessed as decreased firefly luciferase reporter expression2009Nature chemical biology, Feb, Volume: 5, Issue:2
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
AID649235Cardiogenic activity in human embryonic stem cells at 4 uM by MYH6 reporter gene assay relative to control2012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Wnt inhibition correlates with human embryonic stem cell cardiomyogenesis: a structure-activity relationship study based on inhibitors for the Wnt response.
AID1156453Antiproliferative activity against human LoVo cells after 72 hrs by MTT assay2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis and biological evaluation of imidazo[1,2-a]pyrimidines and imidazo[1,2-a]pyridines as new inhibitors of the Wnt/β-catenin signaling.
AID525449Induction of Axin1 stabilization in human DLD1 cells overexpressing IWR-IS by Western blot analysis2009Nature chemical biology, Feb, Volume: 5, Issue:2
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
AID1128299Inhibition of TNKS-2 in mouse L-Wnt-STF cells assessed as disruption of Wnt signaling after 24 hrs by luciferase reporter gene assay2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
Design, synthesis, crystallographic studies, and preliminary biological appraisal of new substituted triazolo[4,3-b]pyridazin-8-amine derivatives as tankyrase inhibitors.
AID722004Inhibition of N-terminal His6-tagged human TNKS1 (1091 to 1325 amino acid residues) after 60 mins by autoparsylation assay2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
Discovery of a class of novel tankyrase inhibitors that bind to both the nicotinamide pocket and the induced pocket.
AID525209Induction of Axin2 accumulation in human DLD1 cells assessed as increase in Thr41 phosphorylated beta-casein levels by Western blot analysis2009Nature chemical biology, Feb, Volume: 5, Issue:2
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
AID649233Inhibition of human recombinant TGFbeta2-induced Smad signaling in HEK293T cells at 0.01 to 5 uM by luciferase reporter gene assay2012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Wnt inhibition correlates with human embryonic stem cell cardiomyogenesis: a structure-activity relationship study based on inhibitors for the Wnt response.
AID661306Inhibition of TNKS22012Journal of medicinal chemistry, Feb-09, Volume: 55, Issue:3
Structural basis of selective inhibition of human tankyrases.
AID525461Induction of Axin2 stabilization in human DLD1 cells assessed as decreased transcription of Axin2 after 2 hrs by RT-PCR method2009Nature chemical biology, Feb, Volume: 5, Issue:2
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
AID1428393Inhibition of recombinant human TNKS2 ADP-ribosyltransferase domain expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay2017Journal of medicinal chemistry, 02-23, Volume: 60, Issue:4
Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors.
AID425207Half life in mouse liver S9 fraction2009Bioorganic & medicinal chemistry letters, Jul-15, Volume: 19, Issue:14
Structure-activity relationship studies of small-molecule inhibitors of Wnt response.
AID661311Inhibition of human PARP2 using NAD+ as substrate after 90 mins by fluorescence analysis2012Journal of medicinal chemistry, Feb-09, Volume: 55, Issue:3
Structural basis of selective inhibition of human tankyrases.
AID525210Induction of Axin2 accumulation in human DLD1 cells assessed as increase in Ser37 phosphorylated beta-casein levels by Western blot analysis2009Nature chemical biology, Feb, Volume: 5, Issue:2
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
AID661312Selectivity ratio of IC50 for human PARP1 to IC50 for human TNSK12012Journal of medicinal chemistry, Feb-09, Volume: 55, Issue:3
Structural basis of selective inhibition of human tankyrases.
AID525208Inhibition of Axin2 protein degradation in human DLD1 cells by Western blot analysis in presence of 100 uM cyclohexamide2009Nature chemical biology, Feb, Volume: 5, Issue:2
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
AID525193Displacement of IWR-PB from Axin2 in HEK293 cells by Western blot method2009Nature chemical biology, Feb, Volume: 5, Issue:2
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
AID1866926Inhibition of TNKS2 (unknown origin)2022Journal of medicinal chemistry, 04-14, Volume: 65, Issue:7
Small-Molecule Inhibitors of Tankyrases as Prospective Therapeutics for Cancer.
AID1428389Inhibition of full length recombinant human His6-tagged PARP3 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay2017Journal of medicinal chemistry, 02-23, Volume: 60, Issue:4
Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors.
AID1156480Inhibition of Wnt/beta-catenin signaling in zebrafish larvae assessed as inhibition of Tcf/Lef transcriptional activity at 10 uM after 72 hrs by GFP reporter assay2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis and biological evaluation of imidazo[1,2-a]pyrimidines and imidazo[1,2-a]pyridines as new inhibitors of the Wnt/β-catenin signaling.
AID1156456Inhibition of Wnt signaling in human HT29 cells assessed as inhibition of beta-catenin-mediated Tcf/Lef transcriptional activity at 25 uM after 24 hrs by dual luciferase reporter gene assay relative to control2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis and biological evaluation of imidazo[1,2-a]pyrimidines and imidazo[1,2-a]pyridines as new inhibitors of the Wnt/β-catenin signaling.
AID425206Half life in mouse blood2009Bioorganic & medicinal chemistry letters, Jul-15, Volume: 19, Issue:14
Structure-activity relationship studies of small-molecule inhibitors of Wnt response.
AID649230Cardiogenic activity in human H9 cells after 14 days by MYH6-mCherry reporter gene assay relative to 4-[(1R,2S,6R,7S)-3,5-dioxo-4-azatricyclo[5.2.1.0~2,6~]dec-8-en-4-yl]-N-quinolin-8-ylbenzamide2012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Wnt inhibition correlates with human embryonic stem cell cardiomyogenesis: a structure-activity relationship study based on inhibitors for the Wnt response.
AID525451Inhibition of Wnt3A mediated fgf20a expression in Zebrafish resected tail fins after 24 hrs post amputation2009Nature chemical biology, Feb, Volume: 5, Issue:2
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
AID525454Decrease in beta-casein accumulation in human DLD1 cells expressing in APC mutant2009Nature chemical biology, Feb, Volume: 5, Issue:2
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
AID525452Inhibition of Wnt3A activity in Zebrafish gastrointestinal tract assessed as decreased BrdU incorporation at 10 uM after 18-14 days2009Nature chemical biology, Feb, Volume: 5, Issue:2
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
AID525441Inhibition of Wnt3A/beta-casein pathway activity in mouse L cell expressing Wnt3a assessed as decrease in phosphorylated Dvl2 level at 10 uM after 24 hrs by Western blot analysis2009Nature chemical biology, Feb, Volume: 5, Issue:2
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
AID1156454Antiproliferative activity against human HepG2 cells after 72 hrs by MTT assay2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis and biological evaluation of imidazo[1,2-a]pyrimidines and imidazo[1,2-a]pyridines as new inhibitors of the Wnt/β-catenin signaling.
AID525206Effect on proteasome in mouse L cell expressing Wnt assessed as accumulation of beta-casein by Western blot analysis2009Nature chemical biology, Feb, Volume: 5, Issue:2
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
AID661305Inhibition of TNKS12012Journal of medicinal chemistry, Feb-09, Volume: 55, Issue:3
Structural basis of selective inhibition of human tankyrases.
AID1428394Inhibition of full length recombinant human His6-tagged PARP10 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay2017Journal of medicinal chemistry, 02-23, Volume: 60, Issue:4
Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors.
AID525203Effect on affinity between Axin2 and beta-casein in HEK293 cell lysate at 10 uM by Western blot analysis2009Nature chemical biology, Feb, Volume: 5, Issue:2
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
AID748256Selectivity ratio of IC50 for PARP1 (unknown origin) to IC50 for 6XHis-tagged tankyrase1 (1091 to 1325) (unknown origin)2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Discovery of novel, induced-pocket binding oxazolidinones as potent, selective, and orally bioavailable tankyrase inhibitors.
AID748261Inhibition of PARP2 (unknown origin) using histone as substrate after 1 hr by luminescence assay2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Discovery of novel, induced-pocket binding oxazolidinones as potent, selective, and orally bioavailable tankyrase inhibitors.
AID1866925Inhibition of TNKS1 (unknown origin)2022Journal of medicinal chemistry, 04-14, Volume: 65, Issue:7
Small-Molecule Inhibitors of Tankyrases as Prospective Therapeutics for Cancer.
AID1866927Inhibition of PARP1 (unknown origin)2022Journal of medicinal chemistry, 04-14, Volume: 65, Issue:7
Small-Molecule Inhibitors of Tankyrases as Prospective Therapeutics for Cancer.
AID525415Induction of Axin2 accumulation in human DLD1 cells assessed as decrease in free beta-casein levels by Western blot analysis2009Nature chemical biology, Feb, Volume: 5, Issue:2
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
AID1754627Cytotoxicity against human HT-29 cells assessed as cell viability at 1.563 to 50 uM measured after 72 hrs by plate reader method2021Bioorganic & medicinal chemistry letters, 08-01, Volume: 45Linderapyrone: A Wnt signal inhibitor isolated from Lindera umbellata.
AID661307Activity of N-terminus hexaHis-tagged human TNSK2 expressed in Escherichia coli BL21 (DE3) cells using biotinylated NAD+ as substrate after 90 mins by Western blot analysis2012Journal of medicinal chemistry, Feb-09, Volume: 55, Issue:3
Structural basis of selective inhibition of human tankyrases.
AID649234Cytotoxicity against human HEK293T cells at 0.2 to 20 uM after 24 hrs by alamar blue assay2012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Wnt inhibition correlates with human embryonic stem cell cardiomyogenesis: a structure-activity relationship study based on inhibitors for the Wnt response.
AID748260Inhibition of tankyrase in human SW480 cells assessed as accumulation of axin2 after 24 hrs by Hoechst dye-based method2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Discovery of novel, induced-pocket binding oxazolidinones as potent, selective, and orally bioavailable tankyrase inhibitors.
AID748258Intrinsic clearance in human liver microsomes2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Discovery of novel, induced-pocket binding oxazolidinones as potent, selective, and orally bioavailable tankyrase inhibitors.
AID661303Inhibition of PARP12012Journal of medicinal chemistry, Feb-09, Volume: 55, Issue:3
Structural basis of selective inhibition of human tankyrases.
AID525442Inhibition of Wnt3A/beta-casein pathway activity in mouse L cell expressing Wnt3a assessed as decrease in phosphorylated Lrp6 level at 10 uM after 24 hrs by Western blot analysis2009Nature chemical biology, Feb, Volume: 5, Issue:2
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
AID1428384Inhibition of full length recombinant human His6-tagged PARP1 expressed in Escherichia coli BL21(DE3) preincubated for 15 mins followed by biotinylated NAD+ addition by chemiluminescence assay2017Journal of medicinal chemistry, 02-23, Volume: 60, Issue:4
Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors.
AID1128298Inhibition of TNKS-1 in mouse L-Wnt-STF cells assessed as disruption of Wnt signaling after 24 hrs by luciferase reporter gene assay2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
Design, synthesis, crystallographic studies, and preliminary biological appraisal of new substituted triazolo[4,3-b]pyridazin-8-amine derivatives as tankyrase inhibitors.
AID525200Effect on interaction between Axin1-GFP and Lrp2 in HEK293 cells transfected with LRP6-myc and Axin2-myc cDNAs at 10 uM by Western blot analysis2009Nature chemical biology, Feb, Volume: 5, Issue:2
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
AID722003Inhibition of N-terminal His6-tagged human TNKS2 (946 to 1162 amino acid residues) after 60 mins by autoparsylation assay2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
Discovery of a class of novel tankyrase inhibitors that bind to both the nicotinamide pocket and the induced pocket.
AID525446Inhibition of Wnt2/beta-casein pathway activity in mouse L cell expressing Wnt2 and STF assessed as decreased firefly luciferase reporter expression2009Nature chemical biology, Feb, Volume: 5, Issue:2
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
AID525197Induction of Axin2 stabilization in human DLD1 cells assessed as inhibition of Wnt/beta-casein pathway2009Nature chemical biology, Feb, Volume: 5, Issue:2
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
AID1866928Inhibition of PAPR2 (unknown origin)2022Journal of medicinal chemistry, 04-14, Volume: 65, Issue:7
Small-Molecule Inhibitors of Tankyrases as Prospective Therapeutics for Cancer.
AID1128314Inhibition of tankyrase in human DLD1 cells assessed as inhibition of TCF-dependent transcriptional activity at 1 to 20 uM after 24 hrs by dual luciferase reporter gene assay2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
Design, synthesis, crystallographic studies, and preliminary biological appraisal of new substituted triazolo[4,3-b]pyridazin-8-amine derivatives as tankyrase inhibitors.
AID525448Inhibition of Wnt3A/beta-casein pathway activity in mouse L cell expressing Wnt3A and STF assessed as decreased firefly luciferase reporter expression2009Nature chemical biology, Feb, Volume: 5, Issue:2
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
AID748254Selectivity ratio of IC50 for PARP2 (unknown origin) to IC50 for 6XHis-tagged tankyrase1 (1091 to 1325) (unknown origin)2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Discovery of novel, induced-pocket binding oxazolidinones as potent, selective, and orally bioavailable tankyrase inhibitors.
AID722000Selectivity ratio of IC50 for N-terminal His6-tagged human TNKS1 (1091 to 1325 amino acid residues) to IC50 for PARP2 (unknown origin)2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
Discovery of a class of novel tankyrase inhibitors that bind to both the nicotinamide pocket and the induced pocket.
AID525462Inhibition of Wnt/beta-casein pathway activity in mouse L cell expressing Wnt and STF assessed as decreased firefly luciferase reporter expression2009Nature chemical biology, Feb, Volume: 5, Issue:2
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
AID748255Selectivity ratio of IC50 for PARP1 (unknown origin) to IC50 for tankyrase2 (unknown origin)2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Discovery of novel, induced-pocket binding oxazolidinones as potent, selective, and orally bioavailable tankyrase inhibitors.
AID525204Effect on interaction between Axin1-GFP and DVl2 in HEK293 cell lysate at 10 uM by Western blot analysis2009Nature chemical biology, Feb, Volume: 5, Issue:2
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
AID1156451Inhibition of Wnt signaling in human HT29 cells assessed as inhibition of beta-catenin-mediated Tcf/Lef transcriptional activity after 24 hrs by dual luciferase reporter gene assay relative to control2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis and biological evaluation of imidazo[1,2-a]pyrimidines and imidazo[1,2-a]pyridines as new inhibitors of the Wnt/β-catenin signaling.
AID649228Chemical stability in phosphate buffer pH 7.4 at 10 uM after 30 hrs by HPLC analysis2012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Wnt inhibition correlates with human embryonic stem cell cardiomyogenesis: a structure-activity relationship study based on inhibitors for the Wnt response.
AID1156457Inhibition of Wnt signaling in human HT29 cells assessed as inhibition of beta-catenin-mediated Tcf/Lef transcriptional activity at 25 uM after 24 hrs by dual luciferase reporter gene assay relative to control in presence of GSK-3beta inhibitor LiCl2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis and biological evaluation of imidazo[1,2-a]pyrimidines and imidazo[1,2-a]pyridines as new inhibitors of the Wnt/β-catenin signaling.
AID1156452Antiproliferative activity against human HT-29 cells after 72 hrs by MTT assay2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis and biological evaluation of imidazo[1,2-a]pyrimidines and imidazo[1,2-a]pyridines as new inhibitors of the Wnt/β-catenin signaling.
AID425209Inhibition of fin regeneration in zebrafish2009Bioorganic & medicinal chemistry letters, Jul-15, Volume: 19, Issue:14
Structure-activity relationship studies of small-molecule inhibitors of Wnt response.
AID748252Half life in mouse plasma at 10 uM after 2 hrs by LC/MS/MS analysis2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Discovery of novel, induced-pocket binding oxazolidinones as potent, selective, and orally bioavailable tankyrase inhibitors.
AID1917763Inhibition of Wnt/beta-catenin transactivation signalling in Wnt3a stimulated human HEK293 cells harbouring TCF/LEF luciferase reporter gene assessed as inhibition TCF-beta-catenin complex formation by measuring luminescence level at 50 uM preincubated fo2022Bioorganic & medicinal chemistry, 11-01, Volume: 73Development of a penetratin-conjugated stapled peptide that inhibits Wnt/β-catenin signaling.
AID661313Selectivity ratio of IC50 for human PARP1 to IC50 for human TNSK22012Journal of medicinal chemistry, Feb-09, Volume: 55, Issue:3
Structural basis of selective inhibition of human tankyrases.
AID425208Half life in mouse hepatocytes2009Bioorganic & medicinal chemistry letters, Jul-15, Volume: 19, Issue:14
Structure-activity relationship studies of small-molecule inhibitors of Wnt response.
AID1156455Antiproliferative activity against human A549 cells after 72 hrs by MTT assay2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis and biological evaluation of imidazo[1,2-a]pyrimidines and imidazo[1,2-a]pyridines as new inhibitors of the Wnt/β-catenin signaling.
AID525207Inhibition of Axin2 protein degradation in human DLD1 cells by Western blot analysis2009Nature chemical biology, Feb, Volume: 5, Issue:2
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
AID525191Induction of Axin2 in human DLD1 cells overexpressing IWR-IS assessed as decrease in Wnt pathway activity at 10 uM by STF reporter assay method2009Nature chemical biology, Feb, Volume: 5, Issue:2
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
AID1156458Inhibition of Wnt/beta-catenin signaling in human HT29 cells assessed as increase in axin2 mRNA expression at 25 uM after 24 hrs by quantitative real-time PCR assay2014European journal of medicinal chemistry, Aug-18, Volume: 83Synthesis and biological evaluation of imidazo[1,2-a]pyrimidines and imidazo[1,2-a]pyridines as new inhibitors of the Wnt/β-catenin signaling.
AID661314Selectivity ratio of IC50 for human PARP2 to IC50 for human TNSK12012Journal of medicinal chemistry, Feb-09, Volume: 55, Issue:3
Structural basis of selective inhibition of human tankyrases.
AID1128315Cytotoxicity against human DLD1 cells assessed as growth inhibition at 1 to 20 uM measured on day 10 by crystal violet staining2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
Design, synthesis, crystallographic studies, and preliminary biological appraisal of new substituted triazolo[4,3-b]pyridazin-8-amine derivatives as tankyrase inhibitors.
AID661308Selectivity ratio of IC50 for PARP2 to IC50 for TNSK12012Journal of medicinal chemistry, Feb-09, Volume: 55, Issue:3
Structural basis of selective inhibition of human tankyrases.
AID525440Inhibition of Wnt3A/beta-casein pathway activity in mouse L cell expressing Wnt3a assessed as inhibition of beta-casein accumulation at 10 uM after 24 hrs by Western blot analysis2009Nature chemical biology, Feb, Volume: 5, Issue:2
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
AID525450Inhibition of caudal fin regeneration after mechanical resection in zebrafish at 10 uM after 7 days2009Nature chemical biology, Feb, Volume: 5, Issue:2
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
AID748264Inhibition of 6XHis-tagged tankyrase1 (1091 to 1325) (unknown origin) after 60 mins in presence of NAD2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Discovery of novel, induced-pocket binding oxazolidinones as potent, selective, and orally bioavailable tankyrase inhibitors.
AID525198Effect on Axin2 subcellular redistribution in human HeLa cells by immunostaining method2009Nature chemical biology, Feb, Volume: 5, Issue:2
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
AID661304Inhibition of PARP22012Journal of medicinal chemistry, Feb-09, Volume: 55, Issue:3
Structural basis of selective inhibition of human tankyrases.
AID1866923Antitumor activity against human MNNG/HOS cells xenografted in mouse assessed as decrease in tumor growth rate at 5 mg/kg, IT administered every other day for 12 days relative to control2022Journal of medicinal chemistry, 04-14, Volume: 65, Issue:7
Small-Molecule Inhibitors of Tankyrases as Prospective Therapeutics for Cancer.
AID748263Inhibition of tankyrase2 (unknown origin) after 60 mins in presence of NAD2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Discovery of novel, induced-pocket binding oxazolidinones as potent, selective, and orally bioavailable tankyrase inhibitors.
AID722002Inhibition of PARP2 (unknown origin)2013Journal of medicinal chemistry, Feb-14, Volume: 56, Issue:3
Discovery of a class of novel tankyrase inhibitors that bind to both the nicotinamide pocket and the induced pocket.
AID525211Induction of Axin2 accumulation in human DLD1 cells assessed as increase in Ser33 phosphorylated beta-casein levels by Western blot analysis2009Nature chemical biology, Feb, Volume: 5, Issue:2
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
AID1894736Inhibition of Wnt/beta-catenin signaling pathway in mouse L Wnt-3A cells harbouring STF-reporter gene assessed as assessed as reduction in luciferase activity incubated for 24 hrs by luciferase reporter assay2021Journal of medicinal chemistry, 04-22, Volume: 64, Issue:8
Carboxylesterase Notum Is a Druggable Target to Modulate Wnt Signaling.
AID525453Decrease in beta-casein accumulation in APC-deficient mouse L cell2009Nature chemical biology, Feb, Volume: 5, Issue:2
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
AID525205Effect on proteasome in mouse L cell expressing Wnt assessed as accumulation of Axin1 by Western blot analysis2009Nature chemical biology, Feb, Volume: 5, Issue:2
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
AID525199Effect on interaction between Axin1-GFP and PP2A in HEK293 cell lysate at 10 uM by Western blot analysis2009Nature chemical biology, Feb, Volume: 5, Issue:2
Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.
AID661310Inhibition of human PARP1 using NAD+ as substrate after 90 mins by fluorescence analysis2012Journal of medicinal chemistry, Feb-09, Volume: 55, Issue:3
Structural basis of selective inhibition of human tankyrases.
AID977608Experimentally measured binding affinity data (IC50) for protein-ligand complexes derived from PDB2014Acta crystallographica. Section D, Biological crystallography, Oct, Volume: 70, Issue:Pt 10
Insights into the binding of PARP inhibitors to the catalytic domain of human tankyrase-2.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (14.29)29.6817
2010's8 (57.14)24.3611
2020's4 (28.57)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.39

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.39 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index5.17 (4.65)
Search Engine Demand Index28.85 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.39)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (7.14%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (92.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]